Efficacy and safety of antidiabetics agents in gestational diabetes mellitus (GDM): a literature review
Abstract
One of the most common metabolic diseases during pregnancy period is gestational diabetes mellitus (GDM). It is associated with several perinatal complications, especially in those who have risk factors such as obesity, polycystic ovary syndrome, and a family history of type 2 diabetes mellitus (DM). Some research has shown that physical exercise and medical nutrition treatment can give beneficial effects to control glycemic and body weight for GDM affected women. Furthermore, pharmacological agents such as insulin and a specific oral antidiabetic can be prescribed safely during pregnancy to decrease maternal glucose blood. Therapy of GDM is needed to control blood for the wellness of the patient during and after the pregnancy. The main treatment therapy for GDM is lifestyle modification, which includes medical nutritional therapy and daily physical exercise. In the special case of disorder glucose level, drug therapy will be given to the patient. Insulin is the chosen drug because it is safe and does not cross the placenta. It is the gold standard pharmacological agent for GDM treatment. However, it still has some disadvantages such as the difficulties of how to use it, how many doses must be given, and the price that tends to be expensive. Consequently, the alternative drug may have to substitute it. Insulin can be substituted by metformin and glyburide (glibenclamide) in the form of oral antidiabetic. They are equal in terms of efficacy and safety compare to insulin as a treatment for GDM. Besides, they are also cheaper, and easy to use.
References
Ryu RJ, Hays KE, Hebert MF. Gestational diabetes mellitus management with oral hypoglycemic agents. Semin Perinatol 2014; 38(8):508-15.
https://doi.org/ 10.1053/j.semperi.2014.08.012
Liang HL, Ma SJ, Xiao YN, Tan HZ. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis. Medicine 2017; 96(38):e7939.
https://doi.org/ 10.1097/MD.0000000000007939
Poolsup N, Suksomboon N, Amin M. Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta analysis. Plos One 2014; 9(10):109985.
American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2016; 39:13-22.
Guo L, Ma J, Tang, J, Hu D, Zhang W, Zhao X. Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis. J Diabetes Res 2019; 2019:9804704.
https://doi.org/10.1155/2019/9804708
Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Broms G, Einarsdottir K, et al. Antidiabetic medication use during pregnancy: an international utilization study. BMJ Open Diabetes Res Care 2019; 7(1):e000759
https://doi.org/ 10.1136/bmjdrc-2019-000759.eCollection 2019.
DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis 2014; 11:E104.
https://doi.org/10.5888/pcd11.130415
Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007; 30(Suppl 2):s141-6.
https://doi.org/10.2337/dc07-s206
Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: The consequences of not treating. Am J Obstet Gynecol 2005; 192(4):989-97.
https://doi.org/10.1016/j.ajog.2004.11.039
Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database Syst Rev 2009; 2009(3):CD003395.
https://doi.org/ 10.1002/14651858.CD003395.pub2
Harrison AL, Shields N, Taylor NF, Frawley HC. Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review. J Physiother 2016; 62(4):188-96.
https://doi.org/ 10.1016/j.jphys.2016.08.003
American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2017; 40:1-132.
Blumer I, Hadar E, Hadden DR, Jovanovic L, Hestman JH, Murad MH, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013; 98(11):4227-49.
https://doi.org/10.1210/jc.2013-2465
National Institute for Health and Care. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. In: National Institute for Health and Care Excellence: Clinical Guidelines London; 2015.
Muktabhant B, Lawrie TA, Lumbiganon P, Laopaiboon M. Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst Rev 2015; 15(6):CD007145.
https://doi.org/10.1002/14651858.CD007145.pub3
Artal R, Catanzaro RB, Gavard JA, Mostello DJ, Friganza JC. A lifestyle intervention of weight-gain restriction: diet and exercise in obese women with gestational diabetes mellitus. Appl Physiol Nutr Metab 2007; 32(3):596-601.
https://doi.org/10.1139/H07-024
Gavard JA, Artal R. Effect of exercise on pregnancy outcome. Clin Obstet Gynecol 2008; 51(2):467-80.
https://doi.org/10.1097/GRF.0b013e31816feb1d
Kintiraki E, Goulis DG. Gestational diabetes mellitus: multi-disciplinary treatment approaches. Metabolism 2018; 86:91-101.
https://doi.org/10.1016/j.metabol.2018.03.025
Garrison A. Screening, diagnosis, and management of gestational diabetes mellitus. Am Fam Physician 2015; 91(7):460-7.
McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019; 5(1):47.
https://doi.org/10.1038/s41572-019-0098-8
Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999; 48(9):1807-14.
https://doi.org/10.2337/diabetes.48.9.1807
Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999; 180(4):903-16.
https://doi.org/10.1016/s0002-9378(99)70662-9
Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001; 86(3):989-93.
https://doi.org/10.1210/jcem.86.3.7339
DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers 2015; 1:15019.
https://doi.org/10.1038/nrdp.2015.19
Harville EW, Viikari JS, Raitakari OT. Preconception cardiovascular risk factors and pregnancy outcome. Epidemiology 2011; 22(5):724-30.
https://doi.org/10.1097/EDE.0b013e318225c960
Hedderson MM, Darbinian JA, Quesenberry CP, Ferrara A. Pregravid cardiometabolic risk profile and risk for gestational diabetes mellitus. Am J Obstet Gynecol 2011; 205(1):55.e1-7.
https://doi.org/10.1016/j.ajog.2011.03.037
Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 1980; 3(3):458-64.
https://doi.org/10.2337/diacare.3.3.458
Beischer NA, Wein P, Sheedy MT, Steffen B. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gynaecol 1996; 36(3):239-47.
https://doi.org/10.1111/j.1479-828x.1996.tb02703.x
Casey BM, Lucas MJ, Mcintire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 1997; 90(6):869-73.
https://doi.org/10.1016/s0029-7844(97)00542-5
Aberg A, Rydhström H, Källén B, Källén K. Impaired glucose tolerance during pregnancy is associated with increased fetal mortality in preceding sibs. Acta Obstet Gynecol Scand 1997; 76(3):212-7.
Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 1998; 21 Suppl 2:B79-84.
Jensen DM, Damm P, Sørensen B, Pedresen LM, Westergaard JG, Korsholm L, et al. Proposed diagnostic thresholds for gestational diabetes mellitus according to a 75-g oral glucose tolerance test. Maternal and perinatal outcomes in 3260 Danish women. Diabet Med 2003; 20(1):51-7.
https://doi.org/10.1046/j.1464-5491.2003.00857.x
Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373(9677):1773-9.
https://doi.org/10.1016/S0140-6736(09)60731-5
Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Webber J, et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study. PLoS Med 2019; 15(1):e100288.
http://doi.org/10.1371/journal.pmed.1002488
Royal College of Obstetricians and Gynaecologists. Diagnosis and Treatment of Gestational Diabetes. London: RCOG; 2011. 1-6.
American Diabetes Association Professional Practice Committee: Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, et al. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022 Jan 1;45(Supplement_1):S232-43.
https://doi: 10.2337/dc22-S015.
American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2021. Diabetes Care 2021; 44(Suppl 1):S200-10.
https://doi.org/10.2337/dc21-s014
Gunderson EP. Gestational diabetes and nutritional recommendations. Curr Diab Rep 2004; 4(5):377-86.
https://doi.org/10.1007/s11892-004-0041-5
American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes-2018. Diabetes Care 2018; 41(Suppl 1):S137-43.
https://doi.org/10.2337/dc18-S013
Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. preventive services task force and the national institutes of health office of medical applications of research. Ann Intern Med 2013; 159(2):123-9.
https://doi.org/10.7326/0003-4819-159-2-201307160-00661
Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358(19):2003-15.
https://doi.org/ 10.1056/NEJMoa0707193
Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One 2013; 8(5):e64585.
https://doi.org/10.1371/journal.pone.0064585
Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343(16):1134-8.
https://doi.org/10.1056/NEJM200010193431601
Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GDV, et al. Are we optimizing gestational diabetes treatment with Glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009; 85(6):607-14.
https://doi.org/10.1038/clpt.2009.5
Malek R, Davis SN. Pharmacokinetics, efficacy and safety of Glyburide for treatment of gestational diabetes mellitus. Expert Opin Drug Metab Toxicol 2016; 12(6):691-9.
https://doi.org/10.1080/17425255.2016.1187131
Mikkelsen MR, Nielsen SB, Stage E, Mathiesen ER, Damm P. High maternal HbA1c is associated with overweight in neonates. Dan Med Bull. 2011; 58(9):A4309.
Wang W, Fang Y, Lin Q. Metformin combined with insulin aspart for ameliorating blood glucose levels and maternal and neonatal outcomes in women with gestational diabetes mellitus and chronic hypertension. Am J Transl Res 2021; 13(5):5596-602.
Nachum Z, Zafran N, Salim R, Hissin N, Hasanein J, Ze Letova YG, et al. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study. Diabetes Care 2017; 40(3):332-7.
https://doi.org/10.2337/dc16-2307
Jiang YF, Chen XY, Ding T, Wang XF, Zhu ZN, Su SW. Comparative efficacy and safety of OADs in management of GDM: network metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2015; 100(5):2071-80.
https://doi.org/10.1210/jc.2014-4403
Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005; 83(5):1575-8.
https://doi.org/10.1016/j.fertnstert.2004.11.051
Charles B, Norris R, Xiao X, Hague W. Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit 2006; 28(1):67-72.
https://doi.org/10.1097/01.ftd.0000184161.52573.0e
Barbour LA, Feig DS. Metformin for gestational diabetes mellitus: progeny, perspective, and a personalized approach. Diabetes Care 2019; 42(3):396-9.
https://doi.org/10.2337/dci18-0055
Barbour LA, Scifres C, Valent AM, Friedman JE, Buchanan TA, Coustan D, et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 2018; 219(4):367.e1-e7.
https://doi.org/10.1016/j.ajog.2018.06.013
Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020; 369:m1361.
https://doi.org/10.1136/bmj.m1361
Li Z, Cheng Y, Wang D, Chen H, Chen H, Ming WK, et al. Incidence rate of type 2 diabetes mellitus after gestational diabetes mellitus: a systematic review and meta-analysis of 170,139 women. J Diabetes Res 2020; 2020:3076463.
https://doi.org/10.1155/2020/3076463
Paglia MJ, Coustan DR. The use of oral antidiabetic medications in gestational diabetes mellitus. Curr Diabetes Rep 2009; 9(4):287-90.
https://doi.org/10.1007/s11892-009-0044-3
Balaji V, Balji MS, Alexander C, Srinivasan A, Suganthi SR, Thiyagarajah A, et al. Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study. Gynecol Endocrinol 2012; 28(7):529-32.
https://doi.org/10.3109/09513590.2011.650661
Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T, et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomized study. BJOG 2011; 118(7):880-5.
https://doi.org/10.1111/j.1471-0528.2010.02763.x
Niromenesh S, Alavi A, Sharbaf FR, Amjadi N, Moosavi S, Akbari S. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomised clinical trial. Diabetes Res Clin Pract 2012; 98(3):422-9.
https://doi.org/10.1016/j.diabres.2012.09.031
Mirzamoradi M, Heidar Z, Faalpoor Z, Naeiji Z, Jamali R. Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: a randomized clinical trial. Acta Med Iran 2015; 53(2):97-103.
Pavithra I, Pillai SK, Vijayaraghavan J. A comparison of insulin and glibenclamide in the treatment of gestational diabetes mellitus. Indian J Obstet Gynecol Res 2016; 2(4):270-5.
Zangeneh M, Veisi F, Ebrahimi B, Rezavand N. Comparison of therapeutic effects of insulin and glibenclamide in gestational diabetes. Iranian Journal of Obstetrics, Gynecology and Infertility 2014; 17(124):1-7.
Ashoush S, El-Said M, Fathi H, Abdelnaby M. Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus. J Obstet Gynaecol Res 2016; 42(6):640-7.
https://doi.org/ 10.1111/jog.12950
Saleh HS, Abdelsalam WA, Mowafy HE, Abd ElHameid AA. Could metformin manage gestational diabetes mellitus instead of insulin?. Int J Reprod Med 2016; 2016:3480629.
https://doi.org/10.1155/2016/3480629
Ardilouze JL, Menard J, Perron P, Houde G, Moutquin JM, Hivert MF, et al. Gestational diabetes mellitus: the first prospective randomised study of metformine-glyburide vs insulin. Diabetologia 2014; 57(Suppl 1):S449-50.
Tertti K, Ekblad U, Koskinen P, Vahlberg T, Ronnemaa T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 2013; 15(3):246-51.
https://doi.org/10.1111/dom.12017
Mukhopadhyay P, Bag TS, Kyal A, Prasun SD, Khalid N. Oral hypoglycaemic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. Journal of the Southern Asian Federation of Obstetrics and Gynaecology 2012; 4(1):28-31.
https://doi.org/10.5005/jp-journals-10006-1167
Hickman MA, McBride R, Boggess KA, Strauss R. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Am J Perinatol 2013; 30(6):483-90.
https://doi.org/10.1055/s-0032-1326994
Mesdaghinia E, Samimi M, Homaei Z, Saberi F, Moosavi SGA, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int J Prev Med 2013; 4(3):327-33.
Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev 2017; 11(11): CD012037.
https://doi.org/10.1002/14651858.CD012037.pub2
Mohamed MA, Abdelmonem AM, Abdellah MA, Elsayed AA. Oral hypoglycaemic as attractive alternative to insulin for the management of diabetes mellitus during pregnancy. Gynecology & Obstetrics 2014; 4(1):1000193.
http://doi.org/10.4172/2161-0932.1000193
Rowan JA, Hague_WM, Gao_W, Battin_MR, Moore_MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358(19):2003-15.
https://doi.org/ 10.1056/NEJMoa0707193
Xu J, Zhao YH, Chen YP, Yuan XL, Wang J, Zhu H, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. ScientificWorldJournal 2014; 2014:926932.
https://doi.org/10.1155/2014/926932
Manderson JG, Patterson CC, Hadden DR, Traub AI, Ennis C, McCance DR. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. Am J Obstet Gynecol 2003 Aug;189(2):507-12.
https://doi: 10.1067/s0002-9378(03)00497-6.
de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995 Nov 9;333(19):1237-41.
https://doi: 10.1056/NEJM199511093331901.
Jovanovic-Peterson L, Peterson CM, Reed GF, et al.; National Institute of Child Health and Human Development—Diabetes in Early Pregnancy Study. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991 Jan;164(1 Pt 1):103-11.
https://doi: 10.1016/0002-9378(91)90637-7.
American Diabetes Association Professional Practice Committee: Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, et al. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022; 45 (Supplement_1): S17–S38.
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007 Jul;30 Suppl 2:S251-60.
https://doi: 10.2337/dc07-s225.
